1-5 of 5
H. Moses Murdock
Close
Sort by
Journal Articles

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Jacqueline S. Garcia, Haesook T Kim, Jennifer Brock, H. Moses Murdock, Corey S. Cutler, Daniel J. DeAngelo, Christopher J. Gibson, Mahasweta Gooptu, Vincent Ho, John Koreth, Marlise R. Luskin, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Richard M. Stone, Martha Wadleigh, Eric S. Winer, Michela Ansuinelli, Eliza Elliot, Geoffrey Fell, Hannah Karp, Jeremy Ryan, Anthony G. Letai, Coleman Lindsley, Robert J Soiffer, Joseph H. Antin, Fiona Loschi, Jerome Ritz
Journal: Blood
Blood (2022) 140 (Supplement 1): 917–919.
https://doi.org/10.1182/blood-2022-157611
Published: 2022
Journal Articles

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

CME Clinical Trials & Observations
H. Moses Murdock, Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan Hambley, Bryan S. Manning, Shannon Gier, Christina Cho, Harrison K. Tsai, Shannon McCurdy, Vincent T. Ho, John Koreth, Robert J. Soiffer, Jerome Ritz, Martin P. Carroll, Sumithira Vasu, Miguel-Angel Perales, Eunice S. Wang, Lukasz P. Gondek, Steven Devine, Edwin P. Alyea, III, R. Coleman Lindsley, Christopher J. Gibson
Journal: Blood
Blood (2022) 139 (24): 3546–3557.
https://doi.org/10.1182/blood.2021014520
Published: 2022
Includes: Supplemental data
Journal Articles

DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant

Christopher J. Gibson, MD, Haesook T. Kim, PhD, H. Moses Murdock, MD, Bryan Hambley, MD, Lin Zhao, MD, Lisa Green, PhD, Mark Fleharty, Brendan Blumenstiel, Carrie Cibulskis, BSc, Christopher D Gocke, MD, Sarah Nikiforow, MD PhD, Amy E. DeZern, MD, Vincent T. Ho, MD, Richard J. Jones, MD, Niall Lennon, PhD, Jerome Ritz, MD, Robert J. Soiffer, MD, Lukasz P. Gondek, MDPhD, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-142925
Published: 2020
Journal Articles

Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML)

R. Coleman Lindsley, MD PhD, Christopher J. Gibson, MD, H. Moses Murdock, BS, Richard M. Stone, MD, Jorge E. Cortes, MD, Geoffrey L. Uy, MD, Tara L. Lin, MD, Ellen K. Ritchie, MD, Thomas Prebet, MD PhD, Robert J. Ryan, MS, Stefan Faderl, MD, Jeffrey E. Lancet, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 15.
https://doi.org/10.1182/blood-2019-124500
Published: 2019
Journal Articles

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission

H. Moses Murdock, BS, Haesook T. Kim, PhD, Bryan Hambley, MD, Pankit Vachhani, MD, Nathan Denlinger, MS, DO, Shannon H. Gier, BS, Christina Cho, MD, Miguel-Angel Perales, MD, John Koreth, MBBS, DPhil, Vincent T. Ho, Robert J. Soiffer, MD, Shannon R. McCurdy, MD, Martin Carroll, MD, Sumithira Vasu, MDMBBS, Eunice S. Wang, MD, Lukasz P. Gondek, MDPhD, Steven Devine, MD, Edwin P. Alyea, III, MD, Christopher J. Gibson, MD, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 48.
https://doi.org/10.1182/blood-2019-125967
Published: 2019